CVS-Aetna $69 Billion Merger Approved With Conditions

The Justice Department antitrust enforcers cleared CVS Health Corp.’s acquisition of Aetna Inc. after the companies took steps to ease regulators’ concerns, moving the nearly $70 billion deal a major step closer.  Critics of the CVS-Aetna deal had worried that the merger could lead to higher drug prices for Medicare Part D beneficiaries. Opponents such as the American Medical Association also said the acquisition could increase insurance premiums and out-of-pocket expenses more broadly.  For more information, see the Wall Street Journal, USA Today, the Washington Post, the New York Times and the Los Angeles Times.